Document Detail


Raynaud, digital ulcers and calcinosis in scleroderma.
MedLine Citation:
PMID:  22835924     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Raynaud, digital ulcers and calcinosis are frequent manifestations of patients with systemic sclerosis. Digital ulcers are seen in more than half of the patients with scleroderma. Hospitalizations, ischemic complications and impairment of hand function are frequently observed in patients with digital ulcers, especially if treatment is delayed. Rapid and intensive treatment escalation in patients with scleroderma and refractory Raynaud's phenomenon is one of the most effective preventive action available in order to avoid the development of digital ulcers and tissue loss.
Authors:
Alejandro Nitsche
Related Documents :
1424844 - Bronchoalveolar lavage in trauma patients for diagnosis of fat embolism syndrome.
2779594 - Stability of the head in pitch (neck flexion-extension): studies in normal subjects and...
16532224 - Measurement of s-100b for risk classification of victims sustaining minor head injury--...
11201644 - Minor head injuries: one year experience according to the new italian guideline.
9816704 - Further studies on htlv-i associated myelopathy in argentina.
2576964 - Course of psychosis in algeria and in france: about 342 cases observed from 1975 to 1985.
Publication Detail:
Type:  Journal Article; Review     Date:  2012-07-25
Journal Detail:
Title:  Reumatología clinica     Volume:  8     ISSN:  1885-1398     ISO Abbreviation:  Reumatol Clin     Publication Date:    2012 Sep-Oct
Date Detail:
Created Date:  2012-09-04     Completed Date:  2013-02-25     Revised Date:  2013-06-18    
Medline Journal Info:
Nlm Unique ID:  101293923     Medline TA:  Reumatol Clin     Country:  Spain    
Other Details:
Languages:  eng     Pagination:  270-7     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 Elsevier España, S.L. All rights reserved.
Affiliation:
Specialist in rheumatology, Servicio de Reumatología, Hospital Alemán; Consultorio de Raynaud, Esclerodermia e Hipertensión Arterial Pulmonar, Sanatorio San José, Ciudad Autónomade Buenos Aires, Argentina. alejandro.nitsche@gmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Calcinosis / drug therapy,  etiology*,  physiopathology
Cell Hypoxia
Combined Modality Therapy
Endothelin-1 / physiology
Endothelium, Vascular / pathology,  physiopathology
Fingers / blood supply,  pathology
Foot Ulcer / drug therapy,  etiology,  physiopathology,  surgery
Humans
Ischemia / drug therapy,  etiology,  physiopathology,  prevention & control
Multicenter Studies as Topic
Platelet Aggregation
Platelet Aggregation Inhibitors / therapeutic use
Randomized Controlled Trials as Topic
Raynaud Disease / diagnosis,  drug therapy,  etiology*,  therapy
Scleroderma, Systemic / complications*,  diagnosis,  drug therapy,  physiopathology
Skin Ulcer / drug therapy,  etiology*,  physiopathology,  surgery
Sulfonamides / therapeutic use
Thrombophilia / etiology
Thrombosis / etiology,  prevention & control
Toes / blood supply,  pathology
Vasoconstriction / physiology
Vasodilator Agents / therapeutic use
Chemical
Reg. No./Substance:
0/Endothelin-1; 0/Platelet Aggregation Inhibitors; 0/Sulfonamides; 0/Vasodilator Agents; Q326023R30/bosentan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The mental health gender-gap in urban India: Patterns and narratives.
Next Document:  Shift work and vascular events: systematic review and meta-analysis.